News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pyng Medical Corp. (PYNGF) is Honored for a Life & Limb Saving Tourniquet Design



12/14/2010 9:48:40 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - December 13, 2010) - Pyng Medical Corp. (TSX VENTURE: PYT) received the silver award from Industrial Designers Society of America for its Mechanical Advantage Tourniquet (MAT®). The award is part of IDSA's Design of the Decade (DoD) competition and falls under the category of "Solution to a developing world social problem".

"We are honored that the MAT® is acknowledged as a Design of the Decade," commented Nadine Gaston, Vice President of Global Sales and Marketing for Pyng.

The MAT® is recognized for its speed and effectiveness, stopping blood loss in 10 seconds and is simple enough to apply one-handed.

The DoD panel awarded 12 golds, six silvers and two bronzes in 12 categories, which included, "Best sustainable design solution", "Design's contribution to business efficiency" and "Biggest contribution to brand growth".

The designs were judged on their benefit to society, benefit to business and innovation, benefit to user and responsibility, and benefit to client and visual appeal.

It clarifies the benefits of the MAT® Tourniquet's superior design at a time when new tourniquet protocols are being implemented world-wide", added Nadine Gaston, Vice President of Global Sales and Marketing.

The panel of judges included top design representatives from consultancies, companies and corporations, including: Chris Bangle, BMW's former director of design; Marc Greuther, chief curator, The Henry Ford; and David Butler, IDSA, vice president of global design, The Coca-Cola Co.

The MAT® is a past winner of the IDSA's Gold Award for Best Medical Product Design of 2006 and in 2007 a finalist for the INDEX Award for best medical product in the world.

About Pyng Medical Corp.

Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng's expanded product portfolio includes a variety of innovative, lifesaving tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Contacts:
Pyng Medical Corp.
Nadine Gaston
VP of Global Sales & Marketing
ngaston@pyng.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES